Summary:
"Beacon - Pulmonary Fibrosis" is a Clinical Trial to Evaluate the Safety and Efficacy of a new study medication in Subjects with Idiopathic Pulmonary Fibrosis
Criteria:- be over 40 years old
- Diagnosed with Pulmonary Fibrosis within the past 7 years
- Have access to medical records to support diagnosis and treatment
- Not diagnosed with cancer within the past 5 years other than basal or squamous cell skin cancer
Qualified Participants May Receive:
- 52 weeks of study medication during the trial at no cost
- Study medical care by Board Certified Pulmonologist and Rheumatologist included
- Compensation for participation up to $3,000